Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novaferon versus interferon alfa-2b for chronic hepatitis B
ChiCTR-TRC-10000984Phase 2Completed
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Jun 2010
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of novaferon in Chronic Hepatitis B (CHB) (2 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoints: HBeAg and HBV DNA. Started Jun 2010; status: completed.
02
Drugs
novaferon
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-TRC-10000984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000984.